Women receiving 17-α-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 4, 2008, Pages 389.e1-389.e4

  Rittenberg, Charles ^a   Sullivan, Scott ^a   Istwan, Niki ^b   Rhea, Debbie ^b   Stanziano, Gary ^b   Newman, Roger ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Matria Healthcare Inc   (United States)

Author keywords

17 alpha hydroxyprogesterone caproate; daily perinatal nursing surveillance; outpatient management; preterm birth prevention; recurrent preterm delivery

Indexed keywords

HYDROXYPROGESTERONE CAPROATE;

ADULT; ARTICLE; FEMALE; GESTATIONAL AGE; HOME CARE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAID; NURSE; NURSING CARE; OUTPATIENT CARE; PATIENT MONITORING; PERINATAL CARE; PHARMACY; PREGNANCY; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEROID THERAPY; TREATMENT OUTCOME;

EID: 52949127024     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.06.070     Document Type: Article

References (10)

1. Martin J.A., Hamilton B.E., and Sutton P.D. Births: Final data for 2005. National vital statistics reports; vol 56 no 6 (2007), National Center for Health Statistics, Hyattsville (MD)
2. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348 (2003) 2379-2385
3. Spong C.Y., Meis P.J., Thom E.A., et al. Progesterone for prevention of recurrent preterm birth: Impact of gestational age at previous delivery. Am J Obstet Gynecol 193 (2005) 1127-1131
4. Hill W.C., Fleming A.D., Martin R.W., et al. Home uterine activity monitoring is associated with a reduction in preterm birth. Obstet Gynecol 76 (1990) 13-18
5. Dyson D.C., Crites Y.M., Ray D.A., and Armstrong M.A. Prevention of preterm birth in high risk patients: The role of education and provider contact versus home uterine activity monitoring. Am J Obstet Gynecol 164 (1991) 756-762
6. Newman R.B. Uterine contraction assessment. Obstet Gynecol Clin North Am 32 (2005) 341-367
7. Pieber D., Allport V.C., Hills F., et al. Interactions between progesterone receptor isoforms in myometrial cells in human labour. Mol Hum Reprod 7 (2001) 875-879
8. Facchinetti F., Paganelli S., Comitini G., et al. Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 196 (2007) 453.e1-453.e4
9. Morrison J.C., Martin J.N., Martin R.W., Gookin K.S., and Wiser W.L. Prevention of preterm birth by ambulatory assessment of uterine activity: A randomized study. Am J Obstet Gynecol 156 (1987) 536-543
10. Rittenberg C, Newman RB, Istwan NB, et al. Preterm birth prevention by 17-α-hydroxyprogesterone caproate versus daily nursing surveillance. J Reprod Med (in press).